Lung-targeted polynitrogenous lipid compounds

TW202637106APending Publication Date: 2026-09-16BEIJING JITAI PHARM TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146375
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-21
Filing Date
2025-11-27
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076548_001
    Figure TWG2TA001076548_001
  • Figure TWG2TA001076548_002
    Figure TWG2TA001076548_002
  • Figure TWG2TA001076548_003
    Figure TWG2TA001076548_003
Patent Text Reader

Abstract

This invention provides a class of lung-targeting polynitrogenous lipid compounds, specifically relating to compounds of formula (I), or isotopic variants, tautomers, or stereoisomers thereof, or pharmaceutically acceptable salts thereof. This invention also provides nanoparticle pharmaceutical compositions comprising the aforementioned compounds, and the use of the aforementioned compounds and compositions thereof in lung-targeted delivery of nucleic acids.
Need to check novelty before this filing date? Find Prior Art